Is Human Neonatal Fibroblast/Keratinocyte Conditioned Media safe in cosmetics?
Human Neonatal Fibroblast/Keratinocyte Conditioned Media has a safety rating of "MODERATE" in our database. EU status: permitted. US status: permitted.
INCI: HUMAN NEONATAL FIBROBLAST/KERATINOCYTE CONDITIONED MEDIA
Human Neonatal Fibroblast/Keratinocyte Conditioned Media (CAS Not assigned) is a cosmetic cosmetic ingredient functioning as Skin conditioning — broader growth factor profile from dual cell culture. EU Regulation 1223/2009 status: permitted. Industrial safety data is also available in the chemical safety database.
View industrial chemical safety profile for CAS Not assigned →
For full compliance data across multiple jurisdictions, use the Substance Compliance tool.
Margin of Safety, dermal absorption, and sensitization profile summaries for Human Neonatal Fibroblast/Keratinocyte Conditioned Media.
Calculate MoS for your specific formulation with the MoS Calculator.
Expert safety assessment and concern-level summary for Human Neonatal Fibroblast/Keratinocyte Conditioned Media.
Human Neonatal Fibroblast/Keratinocyte Conditioned Media has a safety rating of "MODERATE" in our database. EU status: permitted. US status: permitted.
Human Neonatal Fibroblast/Keratinocyte Conditioned Media EU regulatory status: permitted. This is based on EU Regulation 1223/2009 and its amendments.
Human Neonatal Fibroblast/Keratinocyte Conditioned Media functions as: Skin conditioning — broader growth factor profile from dual cell culture. It is classified as a cosmetic ingredient in our database. CAS number: Not assigned.
Check Human Neonatal Fibroblast/Keratinocyte Conditioned Media compliance across multiple jurisdictions:
Scan any product label with Piro — our free ingredient scanner. Point your camera at the ingredients list and get instant safety scores for every ingredient.
Try Piro Free →Paste any INCI list into the Decoder for instant safety analysis, or calculate the Margin of Safety for Human Neonatal Fibroblast/Keratinocyte Conditioned Media in your formulation.